Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
3 hedge funds and large institutions have $5.35M invested in Plus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
40% less funds holding
Funds holding: 5 → 3 (-2)
65% less capital invested
Capital invested by funds: $15.1M → $5.35M (-$9.76M)
73% less call options, than puts
Call options by funds: $6K | Put options by funds: $22K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.79M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.17M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
-$894K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$502K |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$117K |
PSTV Hedge Fund Activity: Q3 2015 in Review
3 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2015, worth a combined $5.35M — down 65% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PSTV and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $3.79M sold.
- 3 institutional investors held Plus Therapeutics (PSTV) as of Q3 2015, down from 5 in Q2 2015.
- Funds reported $5.35M of Plus Therapeutics stock for Q3 2015, down 65% quarter-over-quarter.
- 0 funds opened new Plus Therapeutics positions in Q3 2015 and 2 closed out, a net change of -2 holders.
- The largest Plus Therapeutics seller in Q3 2015 was Susquehanna International Group, an estimated $3.79M sold.
Based on aggregated 13F filings for Q3 2015.